申请人:Jia Zhaozhong
公开号:US20120101275A1
公开(公告)日:2012-04-26
The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as undesired thrombosis and Non Hodgkin's Lymphoma.
本发明涉及公式I-V和其互变异构体或药学上可接受的盐、酯和前药的化合物,其为syk激酶的抑制剂。本发明还涉及用于制备这种化合物的中间体,制备这种化合物的方法,含有这种化合物的制药组合物,抑制syk激酶活性的方法,抑制血小板聚集的方法,以及预防或治疗至少部分由syk激酶活性介导的多种情况的方法,如非霍奇金淋巴瘤和不良血栓形成。